Schedule 13G ownership disclosure

Ironwood Pharmaceuticals Inc

Class A common stock, $0.001 par value per share · CUSIP: 46333X108

Event date: 2024-05-15

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Renaissance Technologies LLC

    Shares: 8,597,198 · Class: 5.37%

  • Renaissance Technologies Holdings Corporation

    Shares: 8,597,198 · Class: 5.37%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001037389-24-000096
Form type
SCHEDULE 13G
Filer
IRONWOOD PHARMACEUTICALS INC
CIK
CIK 1446847
Filed
Nov 13, 2024
Reporting period
May 15, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub